{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-249207","form_type":"8-K","ticker":"VERU","cik":"0000863894","company_name":"VERU INC.","filed_at":"2023-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.182348+00:00","generated_at":"2026-06-10T06:42:42.394102+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Veru amends asset purchase deal; accepts $1M cash + convertible preferred for $4M note from Blue Water Biotech","bullets":["September 29, 2023: Veru deemed $4M promissory note satisfied by $1M cash and 3,000 shares of Blue Water Biotech Series A Convertible Preferred.","Preferred stock has $1,000 stated value per share, convertible after one year into ~5.7M common shares at $0.5254/share, subject to shareholder approval.","Veru received $1M cash on Sept 29; preferred shares to be issued by Oct 3. Buyer must seek shareholder approval by Dec 31, 2023.","Amendment modifies April 2023 asset purchase agreement; Veru's risk includes future defaults and ability to monetize preferred shares.","Blue Water Biotech (formerly Blue Water Vaccines) issued preferred with redemption rights at buyer's option, no holder redemption rights."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-249207","json":"https://secwatch.observer/filing/0001193125-23-249207.json","markdown":"https://secwatch.observer/filing/0001193125-23-249207.md","text":"https://secwatch.observer/filing/0001193125-23-249207.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/863894/000119312523249207/0001193125-23-249207-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/863894/000119312523249207/d536406d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:42:42.394102+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b7692ecec9759bbaff106d4ef13582d95675322d","claim":"VERU INC. amended Amendment with Blue Water Biotech Inc. f/k/a Blue Water Vaccines Inc. (the Purchaser) valued at $1,000,000 (effective 2023-09-29).","evidence_excerpt":"On September 29, 2023, Veru Inc. (the “Company”) entered into an Amendment to Asset Purchase Agreement (the “Amendment “) with Blue Water Biotech Inc. f/k/a Blue Water Vaccines Inc. (the “Purchaser”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/863894/000119312523249207/0001193125-23-249207-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Blue Water Biotech Inc. f/k/a Blue Water Vaccines Inc. (the Purchaser)"},{"label":"Value","value":"$1,000,000"},{"label":"Effective","value":"2023-09-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}